Lipocine LPCN
NASDAQ LPCN
$1.60 -0.02 (-1.22%)
As of: Oct 21, 2026 · 1:40 PM EDT

Lipocine (LPCN) Other financing activities (2011 - 2014)

Updated

Analysis

Lipocine (LPCN) Other financing activities (2011 - 2014) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,133.99 Bn 1,102.58 Bn 19.71 Bn
2 Johnson & Johnson 615.70 Bn 534.23 Bn 17.26 Bn
3 AbbVie 501.05 Bn 474.16 Bn 12.70 Bn
4 Merck 367.41 Bn 321.79 Bn 12.21 Bn
5 Novartis Ag 297.75 Bn 261.74 Bn 11.24 Bn
6 Astrazeneca 261.20 Bn 234.88 Bn 12.86 Bn
7 Amgen 235.55 Bn 190.95 Bn 7.24 Bn
8 Gilead Sciences 190.64 Bn 164.84 Bn 6.22 Bn
9 Pfizer 169.29 Bn 115.93 Bn 10.94 Bn
10 Lipocine 8.66 Mn -59.05 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2014 -271,183.00
Dec 31, 2011 9,500.00
API Access

Lipocine Other financing activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-financing-activities&ticker=LPCN&period=max&api_key=YOUR_API_KEY